About Mitofam
Add Pedigree
Help
About Mitofam
Add Pedigree
Help
MT-CYB
A15579G
A15662G
A15662G-F1
C15347T
C15620A
C15620A-F1
G14846A
G14846A-F1
C15800T
G15043A
G15043A-F1
G15059A
G15077A
G15077A-F1
G15084A
G15092A
G15150A
G15168A
G15170A
G15215A
G15243A
G15242A
G15350A
G15497A
G15497A-F1
G15498A
G15498A-F2
G15723A
G15699C
G15699C-F1
G15615A
G15615A-F1
G15761A
G15762A
G15812A
G15812A-F1
T14849C
T14864C
T15287C
T15287C-F1
Edit by Mitofam Team
-
+
首页
G15170A
# **General Information** | **Position** | **15170** | **Variant** | **m.15170G\>A** | **Locus** | **MT\-CYB** | **Amino\-AcidChange** | **G142Term** | | --- | --- | --- | --- | --- | --- | --- | --- | | **Homoplasmy** | \- | **Heteroplasmy** | \+ | **APOGEE2** | NA | **Pathogenicity** | Reported | "Pathogenicity" status is derived from published literature or predictions from bioinformatics tools. Researchers and clinicians are cautioned that additional data and/or analysis may still be necessary to confirm the pathological significance of these variants. For more information, please see [Mitofam Info](https://mitofam.com/doc/385/). # **Pedigree Information** The **m.15170G\>A** variant in MT\-CYB has been reported in 1 pedigree. To date, 1 carrier has been reported. Reported mutation loads ranged from 0% to 99%, with a median of 0% overall; affected carriers showed mutation loads from 0% to 99%, with a median of 0%. In one affected carrier, the mutation was undetectable in blood (0%) and fibroblasts (0%) but exceeded 20% in muscle (99%). The main clinical manifestations among affected carriers included exercise intolerance and myalgia. | **No.** | **Position** | **Variant** | **Family ID** | **Nationality** | **Diseases** | **Unaffected Maternal Relatives** | **Affected Maternal Relatives** | **Publication Year** | **PMID/Ref** | **Note** | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1 | 15170 | m.15170G\>A | G15170A\-F1 | Italy | Exercise intolerance, myalgia | 0 | 0 | 2003 | [14506725](https://pubmed.ncbi.nlm.nih.gov/14506725/) | | # **Carrier Information** | **No.** | **Position** | **Variant** | **Family ID** | **Carrier ID** | **Type (Fam/De novo/Uninf)** | **Gender (F/M)** | **Proband (Y/N)** | **Affected (Y/N)** | **Die/Alive(D/A)** | **Age** | **Blood Mutant Level** | **Muscle Mutant level** | **Urine Mutant level** | **Other Mutant level** | **Clinical Features** | **Note** | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1 | 15170 | m.15170G\>A | G15170A\-F1 | G15170A\-F1\-I1 | Uninf | F | Y | Y | A | 40 | 0 | 99% | / | 0% (F) | Exercise intolerance, myalgia | | For abbreviations and other usage instructions, please see [Mitofam Info](https://mitofam.com/doc/385/).
Haoyu He
2026年6月30日 16:26
转发
收藏文档
上一篇
下一篇
手机扫码
复制链接
手机扫一扫转发分享
复制链接
分享
链接
类型
密码
更新密码
有效期
Markdown文件
Word文件
PDF文档
PDF文档(打印)